Current Drug Targets


Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556


Become EABM
Become Reviewer

Editorial: Drug Targets and Biomarkers for Obstetric/Gynecologic/Reproductive Diseases free to download

Volume:18   Issue: 10
Pp: 1113-1115
Xueqiong Zhu* and Shi-Wen Albert Jiang*
DOI: 10.2174/138945011810170710184519

Epigenetic Effects of Environmental Chemicals on Reproductive Biology

Volume:18   Issue: 10
Pp: 1116-1124
Maria Strazzullo* and Maria Rosaria Matarazzo
DOI: 10.2174/1389450117666161025100125

The Benefits and Side Effects of Bevacizumab for the Treatment of Recurrent Ovarian Cancer

Volume:18   Issue: 10
Pp: 1125-1131
Wenwen Zhang, Zhaojun Shen, Hui Luo, Xiaoli Hu, Lihong Zheng and Xueqiong Zhu*
DOI: 10.2174/1389450117666160502150237

Reproductive Toxicity of T Cells in Early Life: Abnormal Immune Development and Postnatal Diseases

Volume:18   Issue: 10
Pp: 1132-1141
Han-xiao Liu, Aifang Jiang, Ting Chen, Wen Qu, Hui-yi Yan and Jie Ping*
DOI: 10.2174/1389450117666161124145641

CEBP Epigenetic Dysregulation as a Drug Target for the Treatment of Hematologic and Gynecologic Malignancies

Volume:18   Issue: 10
Pp: 1142-1151
Chengming Sun, Ping Duan and Caifu Luan*
DOI: 10.2174/1389450117666161228160455

Oncogenic Role of SET/I2PP2A for Gynecologic Cancers

Volume:18   Issue: 10
Pp: 1152-1157
Shi-wen Jiang, Siliang Xu, Haibin Chen, Jiayin Liu* and Ping Duan
DOI: 10.2174/1389450118666170328114506

Serum HE4 Level as a Biomarker to Predict the Recurrence of Gynecologic Cancers

Volume:18   Issue: 10
Pp: 1158-1164
Jinping Li, Haibin Chen, John R. Curcuru, Sheena Patel, Taylor O. Johns, Dimple Patel, Hua Qian* and Shi-wen Jiang*
DOI: 10.2174/1389450118666170404154929

Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia

Volume:18   Issue: 10
Pp: 1165-1170
Xuejing Song, Xiucui Luo, Quansheng Gao, Yuhuan Wang, Qing Gao and Wei Long*
DOI: 10.2174/1389450118666170404160000

Targeted Therapy of Ovarian Cancer with Angiogenesis Inhibitors

Volume:18   Issue: 10
Pp: 1171-1178
Ping Duan, Lili Fan, Quansheng Gao, Bal Mukunda Silwal, Mulan Ren, Yang Shen* and Wanglei Qu*
DOI: 10.2174/1389450118666170329095807

Effect of Genetic Polymorphisms (SNPs) in CHRNA7 Gene on Response to Acetylcholinesterase Inhibitors (AChEI) in Patients with Alzheimer’s Disease

Volume:18   Issue: 10
Pp: 1179-1190
Patrizia Russo*, Aliaksei Kisialiou, Rossana Moroni, Giulia Prinzi and Massimo Fini
DOI: 10.2174/1389450116666151001111826

Recent Advancement and Technological Aspects of Pulsatile Drug Delivery System - A Laconic Review

Volume:18   Issue: 10
Pp: 1191-1203
Vinay Pandit, Ajay Kumar, Mahendra S. Ashawat, Chander P. Verma and Pravin Kumar*
DOI: 10.2174/1389450117666160208144343

Molecular Targets and Angiogenesis in Renal Cell Carcinoma, A Multitarget Approach: Mini Review

Volume:18   Issue: 10
Pp: 1204-1213
Simone A.M. Badal*, William D. Aiken and Sheray N. Chin
DOI: 10.2174/1389450117666160502152518

Tankyrase as a Novel Molecular Target in Cancer and Fibrotic Diseases

Volume:18   Issue: 10
Pp: 1214-1224
Tiruveedi Vijaya Lakshmi, Swarna Bale, Amit Khurana and Chandraiah Godugu*
DOI: 10.2174/1389450117666160715152503